Search Browse Earnings

Zai Lab Ltd — SlamSEC

Zai Lab Ltd

Nasdaq:ZLAB

Pharmaceutical Preparations·SHANGHAI

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$266.7M

+25.4% YoY

FY 2025

Adj. EBITDA

-$357.5M

-134.1% margin

FY 2025

Net Income

-$334.6M

-125.5% margin

FY 2025

EPS (Diluted)

-$0.35

FY 2025

Stock Price

$18.37

-2.6%

2026-03-13

52W Range

$15.96 – $44.34

P/E Ratio

-52.5x

Market Cap

$1.6B

Cash

$449.7M

FY 2025

Total Debt

$131.7M

FY 2025

Net Cash

$318.0M

FY 2025

Enterprise Value

$1.3B

Debt / EBITDA

0.9x

FY 2025

EV / EBITDA

-3.7x

Employees

—